UPDATE: JPMorgan Downgrades Eidos Therapeutics (EIDX) to Neutral
Tweet Send to a Friend
(Updated - May 14, 2020 4:47 AM EDT)
(updating comment)JPMorgan analyst Anupam Rama downgraded Eidos Therapeutics (NASDAQ: EIDX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)JPMorgan analyst Anupam Rama downgraded Eidos Therapeutics (NASDAQ: EIDX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
